Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma

World Journal of Gastroenterology

Volumn 21, Issue 7, 2015, Pages 2191-2198

  Wang, Jin Shen ^a   Jing, Chang Qing ^a   Shan, Ke Shu ^a   Chen, Yue Zhi ^a   Guo, Xiao Bo ^a   Cao, Zhi Xin ^a   Mu, Lin Jun ^a   Peng, Li Pan ^a   Zhou, Ming Liang ^a   Li, Le Ping ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Hypoxia inducible factor 1 ; Immunohistochemical staining; Prognosis; Semaphorin 4D

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG; CD100 ANTIGEN; HIF1A PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL NUCLEUS; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; RECTUM MUCOSA; CARCINOMA; CHEMISTRY; CHI SQUARE DISTRIBUTION; COLON RESECTION; COLORECTAL NEOPLASMS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SECONDARY; TREATMENT OUTCOME; UPREGULATION;

ADULT; AGED; ANTIGENS, CD; BIOMARKERS, TUMOR; CARCINOMA; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SEMAPHORINS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84922753155     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i7.2191     Document Type: Article

References (26)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society, 2006
4. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003; 9: 677-684 [PMID: 12778166 DOI: 10.1038/nm0603-677]
5. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514 [PMID: 7539918]
6. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002; 109: 777-785 [PMID: 11901186 DOI: 10.1172/JCI200214105]
7. Siebold C, Berrow N, Walter TS, Harlos K, Owens RJ, Stuart DI, Terman JR, Kolodkin AL, Pasterkamp RJ, Jones EY. High-resolution structure of the catalytic region of MICAL (molecule interacting with CasL), a multidomain flavoenzyme-signaling molecule. Proc Natl Acad Sci USA 2005; 102: 16836-16841 [PMID: 16275925 DOI: 10.1073/pnas.0504997102]
8. Pasterkamp RJ, Kolodkin AL. Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 2003; 13: 79-89 [PMID: 12593985 DOI: 10.1016/S0959-4388(03)00003-5]
9. Kolodkin AL, Matthes DJ, Goodman CS. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75: 1389-1399 [PMID: 8269517 DOI: 10.1016/0092-8674(93)90625-Z]
10. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005; 436: 193-200 [PMID: 16015319 DOI: 10.1038/nature03875]
11. Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 1996; 93: 11780-11785 [PMID: 8876214 DOI: 10.1073/pnas.93.21.11780]
12. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T, Yukawa K, Ikawa M, Okabe M, Parnes JR, Yoshida K, Kikutani H. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 2000; 13: 633-642 [PMID: 11114376 DOI: 10.1016/S1074-7613(00)00063-7]
13. Sun Q, Zhou H, Binmadi NO, Basile JR. Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J Biol Chem 2009; 284: 32066-32074 [PMID: 19762474 DOI: 10.1074/jbc.M109.057166]
14. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000; 60: 4693-4696 [PMID: 10987269]
15. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678-685 [PMID: 18259193 DOI: 10.1038/cdd.2008.21]
16. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; 2007: cm8 [PMID: 17925579 DOI: 10.1126/stke.4072007cm8]
17. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, Bussolino F, Giordano S. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005; 105: 4321-4329 [PMID: 15632204 DOI: 10.1182/blood-2004-07-2885]
18. Basile JR, Barac A, Zhu T, Guan KL, Gutkind JS. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004; 64: 5212-5224 [PMID: 15289326 DOI: 10.1158/0008-5472.CAN-04-0126]
19. Zhang Y, Liu B, Ma Y, Jin B. Sema 4D/CD100-plexin B is a multifunctional counter-receptor. Cell Mol Immunol 2013; 10: 97-98 [PMID: 23262975 DOI: 10.1038/cmi.2012.65]
20. Chen Y, Zhang L, Lv R, Zhang WQ. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer. Asian Pac J Cancer Prev 2013; 14: 5883-5890 [PMID: 24289594 DOI: 10.7314/APJCP.2013.14.10.5883]
21. Liu H, Yang Y, Xiao J, Yang S, Liu Y, Kang W, Li X, Zhang F. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Microvasc Res 2014; 93: 1-8 [PMID: 24603190 DOI: 10.1016/j.mvr.2014.02.007]
22. Matsumura M, Chiba Y, Lu C, Amaya H, Shimomatsuya T, Horiuchi T, Muraoka R, Tanigawa N. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer. Cancer Lett 1998; 128: 55-63 [PMID: 9652793 DOI: 10.1016/S0304-3835(98)00051-2]
23. Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res 2002; 62: 1326-1329 [PMID: 11888900]
24. Zhou H, Yang YH, Binmadi NO, Proia P, Basile JR. The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma. Exp Cell Res 2012; 318: 1685-1698 [PMID: 22652457 DOI: 10.1016/j.yexcr.2012.04.019]
25. Zhou H, Binmadi NO, Yang YH, Proia P, Basile JR. Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression. Angiogenesis 2012; 15: 391-407 [PMID: 22476930 DOI: 10.1007/s10456-012-9268-y]
26. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001; 7: 1661-1668 [PMID: 11410504]